2015-2025 Global Duchenne Muscular Dystrophy Market Research by Type, End-Use and Region
SUMMARY
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- PTC Therapeutics
- Sarepta Therapeutics
- Bristol-Myers Squibb
- ITALFARMACO
- BioMarin
- Daiichi Sankyo
- Solid Biosciences
- Summit Therapeutics
- FibroGen
- NS Pharma
- Pfizer
- ReveraGen BioPharma
- Wave Life
- Genethon
- Santhera Pharmaceuticals
- Deflazacort
- Prednisone
- Others
- Male
- Female
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDuchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table America Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure America Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Duchenne Muscular Dystrophy Production Forecast
Figure Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Duchenne Muscular Dystrophy Forecast by Type
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2025 (Volume)
8.3 Global Duchenne Muscular Dystrophy Forecast by End-Use (2020E-2025F)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Duchenne Muscular Dystrophy Forecast by Region (2020E-2025F)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by Region in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 PTC Therapeutics
9.1.1 PTC Therapeutics Profile
Table PTC Therapeutics Overview List
9.1.2 PTC Therapeutics Products & Services
9.1.3 PTC Therapeutics Company Dynamics & News
9.1.4 PTC Therapeutics Business Operation Conditions
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Sarepta Therapeutics
9.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
9.2.2 Sarepta Therapeutics Products & Services
9.2.3 Sarepta Therapeutics Company Dynamics & News
9.2.4 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
9.3.2 Bristol-Myers Squibb Products & Services
9.3.3 Bristol-Myers Squibb Company Dynamics & News
9.3.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 ITALFARMACO
9.4.1 ITALFARMACO Profile
Table ITALFARMACO Overview List
9.4.2 ITALFARMACO Products & Services
9.4.3 ITALFARMACO Company Dynamics & News
9.4.4 ITALFARMACO Business Operation Conditions
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 BioMarin
9.5.1 BioMarin Profile
Table BioMarin Overview List
9.5.2 BioMarin Products & Services
9.5.3 BioMarin Company Dynamics & News
9.5.4 BioMarin Business Operation Conditions
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Daiichi Sankyo
9.6.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
9.6.2 Daiichi Sankyo Products & Services
9.6.3 Daiichi Sankyo Company Dynamics & News
9.6.4 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Solid Biosciences
9.7.1 Solid Biosciences Profile
Table Solid Biosciences Overview List
9.7.2 Solid Biosciences Products & Services
9.7.3 Solid Biosciences Company Dynamics & News
9.7.4 Solid Biosciences Business Operation Conditions
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Summit Therapeutics
9.8.1 Summit Therapeutics Profile
Table Summit Therapeutics Overview List
9.8.2 Summit Therapeutics Products & Services
9.8.3 Summit Therapeutics Company Dynamics & News
9.8.4 Summit Therapeutics Business Operation Conditions
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 FibroGen
9.9.1 FibroGen Profile
Table FibroGen Overview List
9.9.2 FibroGen Products & Services
9.9.3 FibroGen Company Dynamics & News
9.9.4 FibroGen Business Operation Conditions
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 NS Pharma
9.10.1 NS Pharma Profile
Table NS Pharma Overview List
9.10.2 NS Pharma Products & Services
9.10.3 NS Pharma Company Dynamics & News
9.10.4 NS Pharma Business Operation Conditions
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Pfizer
9.11.1 Pfizer Profile
Table Pfizer Overview List
9.11.2 Pfizer Products & Services
9.11.3 Pfizer Company Dynamics & News
9.11.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 ReveraGen BioPharma
9.12.1 ReveraGen BioPharma Profile
Table ReveraGen BioPharma Overview List
9.12.2 ReveraGen BioPharma Products & Services
9.12.3 ReveraGen BioPharma Company Dynamics & News
9.12.4 ReveraGen BioPharma Business Operation Conditions
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
9.13 Wave Life
9.13.1 Wave Life Profile
Table Wave Life Overview List
9.13.2 Wave Life Products & Services
9.13.3 Wave Life Company Dynamics & News
9.13.4 Wave Life Business Operation Conditions
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Genethon
9.14.1 Genethon Profile
Table Genethon Overview List
9.14.2 Genethon Products & Services
9.14.3 Genethon Company Dynamics & News
9.14.4 Genethon Business Operation Conditions
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
9.15 Santhera Pharmaceuticals
9.15.1 Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Overview List
9.15.2 Santhera Pharmaceuticals Products & Services
9.15.3 Santhera Pharmaceuticals Company Dynamics & News
9.15.4 Santhera Pharmaceuticals Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Duchenne Muscular Dystrophy Sales Volume by Companies, 2015-2020E (Volume)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure America Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Asia Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Oceania Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Africa Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON DUCHENNE MUSCULAR DYSTROPHY INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 DUCHENNE MUSCULAR DYSTROPHY INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDuchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table America Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure America Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Duchenne Muscular Dystrophy Production Forecast
Figure Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Duchenne Muscular Dystrophy Forecast by Type
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2025 (Volume)
8.3 Global Duchenne Muscular Dystrophy Forecast by End-Use (2020E-2025F)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Duchenne Muscular Dystrophy Forecast by Region (2020E-2025F)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by Region in 2025 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 PTC Therapeutics
9.1.1 PTC Therapeutics Profile
Table PTC Therapeutics Overview List
9.1.2 PTC Therapeutics Products & Services
9.1.3 PTC Therapeutics Company Dynamics & News
9.1.4 PTC Therapeutics Business Operation Conditions
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Sarepta Therapeutics
9.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
9.2.2 Sarepta Therapeutics Products & Services
9.2.3 Sarepta Therapeutics Company Dynamics & News
9.2.4 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Bristol-Myers Squibb
9.3.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
9.3.2 Bristol-Myers Squibb Products & Services
9.3.3 Bristol-Myers Squibb Company Dynamics & News
9.3.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 ITALFARMACO
9.4.1 ITALFARMACO Profile
Table ITALFARMACO Overview List
9.4.2 ITALFARMACO Products & Services
9.4.3 ITALFARMACO Company Dynamics & News
9.4.4 ITALFARMACO Business Operation Conditions
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 BioMarin
9.5.1 BioMarin Profile
Table BioMarin Overview List
9.5.2 BioMarin Products & Services
9.5.3 BioMarin Company Dynamics & News
9.5.4 BioMarin Business Operation Conditions
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Daiichi Sankyo
9.6.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
9.6.2 Daiichi Sankyo Products & Services
9.6.3 Daiichi Sankyo Company Dynamics & News
9.6.4 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Solid Biosciences
9.7.1 Solid Biosciences Profile
Table Solid Biosciences Overview List
9.7.2 Solid Biosciences Products & Services
9.7.3 Solid Biosciences Company Dynamics & News
9.7.4 Solid Biosciences Business Operation Conditions
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Summit Therapeutics
9.8.1 Summit Therapeutics Profile
Table Summit Therapeutics Overview List
9.8.2 Summit Therapeutics Products & Services
9.8.3 Summit Therapeutics Company Dynamics & News
9.8.4 Summit Therapeutics Business Operation Conditions
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 FibroGen
9.9.1 FibroGen Profile
Table FibroGen Overview List
9.9.2 FibroGen Products & Services
9.9.3 FibroGen Company Dynamics & News
9.9.4 FibroGen Business Operation Conditions
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 NS Pharma
9.10.1 NS Pharma Profile
Table NS Pharma Overview List
9.10.2 NS Pharma Products & Services
9.10.3 NS Pharma Company Dynamics & News
9.10.4 NS Pharma Business Operation Conditions
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Pfizer
9.11.1 Pfizer Profile
Table Pfizer Overview List
9.11.2 Pfizer Products & Services
9.11.3 Pfizer Company Dynamics & News
9.11.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 ReveraGen BioPharma
9.12.1 ReveraGen BioPharma Profile
Table ReveraGen BioPharma Overview List
9.12.2 ReveraGen BioPharma Products & Services
9.12.3 ReveraGen BioPharma Company Dynamics & News
9.12.4 ReveraGen BioPharma Business Operation Conditions
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
9.13 Wave Life
9.13.1 Wave Life Profile
Table Wave Life Overview List
9.13.2 Wave Life Products & Services
9.13.3 Wave Life Company Dynamics & News
9.13.4 Wave Life Business Operation Conditions
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Genethon
9.14.1 Genethon Profile
Table Genethon Overview List
9.14.2 Genethon Products & Services
9.14.3 Genethon Company Dynamics & News
9.14.4 Genethon Business Operation Conditions
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
9.15 Santhera Pharmaceuticals
9.15.1 Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Overview List
9.15.2 Santhera Pharmaceuticals Products & Services
9.15.3 Santhera Pharmaceuticals Company Dynamics & News
9.15.4 Santhera Pharmaceuticals Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Duchenne Muscular Dystrophy Sales Volume by Companies, 2015-2020E (Volume)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure America Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Asia Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Oceania Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
Figure Africa Duchenne Muscular Dystrophy Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON DUCHENNE MUSCULAR DYSTROPHY INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 DUCHENNE MUSCULAR DYSTROPHY INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2020E-2025F (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2020E-2025F (Volume)
Table PTC Therapeutics Overview List
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Overview List
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ITALFARMACO Overview List
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Overview List
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Solid Biosciences Overview List
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Summit Therapeutics Overview List
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FibroGen Overview List
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NS Pharma Overview List
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ReveraGen BioPharma Overview List
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
Table Wave Life Overview List
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genethon Overview List
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
Table Santhera Pharmaceuticals Overview List
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Duchenne Muscular Dystrophy Sales Volume by Companies, 2015-2020E (Volume)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table America Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Duchenne Muscular Dystrophy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Duchenne Muscular Dystrophy Revenue by Type, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Production Volume by Type, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Duchenne Muscular Dystrophy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Duchenne Muscular Dystrophy Consumption Volume by Region, 2015-2020 (Volume)
Table Global Duchenne Muscular Dystrophy Revenue by Type, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Production Volume by Type, 2020E-2025F (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Duchenne Muscular Dystrophy Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Duchenne Muscular Dystrophy Consumption Volume by Region, 2020E-2025F (Volume)
Table PTC Therapeutics Overview List
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Overview List
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ITALFARMACO Overview List
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Overview List
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Solid Biosciences Overview List
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Summit Therapeutics Overview List
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FibroGen Overview List
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NS Pharma Overview List
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ReveraGen BioPharma Overview List
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
Table Wave Life Overview List
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genethon Overview List
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
Table Santhera Pharmaceuticals Overview List
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Duchenne Muscular Dystrophy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Duchenne Muscular Dystrophy Sales Volume by Companies, 2015-2020E (Volume)
Table Global Duchenne Muscular Dystrophy Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDuchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure America Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2025 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by Region in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaDuchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Duchenne Muscular Dystrophy Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Europe Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure America Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Asia Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Oceania Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Revenue Share by Type in 2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Production Volume Share by Type in 2020 (Volume)
Figure Africa Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Duchenne Muscular Dystrophy Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Duchenne Muscular Dystrophy Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Duchenne Muscular Dystrophy Revenue Share by Type in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Production Volume Share by Type in 2025 (Volume)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Value Share by Region in 2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Consumption Volume Share by Region in 2025 (Volume)
